Dan Sisler is a Scientific Affairs Liaiso for Tempus AI, a data driven precision medicine company in the cancer genomics, and pharmacogenomics space. During his time at Tempus AI, Dan has provided medical and scientific support for numerous commercial launches including our flagship MRD testing product.

Prior to transitioning to Tempus, Dan gained his PhD in cancer biology from the University of Colorado - Anschutz Medical Campus, focusing on development of rational therapeutic targets and mechanisms of resistance in KRAS mutant lung cancer.